Baxion
Screening
Tags
Alerts
Theme
Atyr Pharma Inc.
ATYR
·
NASDAQ
·
$0.48
Share Price as of 11/2
·
$47M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
03/05/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
10/27/26
8-K
Current report
10/16/26
8-K
Current report
09/24/26
8-K
Current report
08/07/26
8-K
Current report
07/31/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/07/26
S-3
Shelf registration
08/07/25
S-8
Registration of securities for employees
08/07/25
424B5
Prospectus supplement
12/23/24
S-8
Registration of securities for employees
08/13/24
Proxies
Filter
DEF 14A
Definitive proxy
09/11/26
PRE 14A
Preliminary proxy
08/31/26
DEF 14A
Definitive proxy
03/26/26
DEFA14A
Additional proxy materials
03/26/26
PRE 14A
Preliminary proxy
03/12/26
Ownership
Filter
Form 3
Initial insider ownership
10/01/26
Form 4
Insider transaction
10/01/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
SC 13G/A
Beneficial ownership (amended)
07/27/26
SC 13G/A
Beneficial ownership (amended)
06/05/26
Other
Filter
ARS
Annual report to shareholders
03/26/26
EFFECT
Request for effectiveness
08/18/25
CORRESP
Correspondence with the SEC
08/13/25
UPLOAD
Letter from the SEC
08/13/25
ARS
Annual report to shareholders
03/19/25
Latest Filings
Filter
8-K
Current report
10/27/26
8-K
Current report
10/16/26
8-K
Current report
09/24/26
DEF 14A
Definitive proxy
09/11/26
PRE 14A
Preliminary proxy
08/31/26
Ownership
Filter
Form 3
Initial insider ownership
10/01/26
Form 4
Insider transaction
10/01/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
SC 13G/A
Beneficial ownership (amended)
07/27/26
SC 13G/A
Beneficial ownership (amended)
06/05/26